細菌性結膜炎治療の世界市場（～2026年）

• 英文タイトル：Global Bacterial Conjunctivitis Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY11011
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は細菌性結膜炎治療のグローバル市場について調査・分析したレポートです。種類別（フルオロキノロン、アミノグリコシド、マクロライド、その他）市場規模、用途別（軟膏、点眼薬、薬品）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別細菌性結膜炎治療の競争状況、市場シェア
・世界の細菌性結膜炎治療市場：種類別市場規模 2015年-2020年（フルオロキノロン、アミノグリコシド、マクロライド、その他）
・世界の細菌性結膜炎治療市場：種類別市場規模予測 2021年-2026年（フルオロキノロン、アミノグリコシド、マクロライド、その他）
・世界の細菌性結膜炎治療市場：用途別市場規模 2015年-2020年（軟膏、点眼薬、薬品）
・世界の細菌性結膜炎治療市場：用途別市場規模予測 2021年-2026年（軟膏、点眼薬、薬品）
・北米の細菌性結膜炎治療市場分析：米国、カナダ
・ヨーロッパの細菌性結膜炎治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの細菌性結膜炎治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の細菌性結膜炎治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの細菌性結膜炎治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Bayer、Hoffman-LaRoche、Merck、Novartis、Pfizer、Akorn、Allergan、Perrigo、Santen Pharmaceutical、Valeant Pharmaceuticals International
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Bacterial conjunctivitis is a serious eye infection caused by several types of bacteria.
The aforementioned figures clarify that it is one of the most common eye problems affecting people of all ages across the U.S. Such higher prevalence of the disease definitely prompts at increasing demand for effective drugs against bacterial conjunctivitis.

Market Analysis and Insights: Global Bacterial Conjunctivitis Treatment Market
The global Bacterial Conjunctivitis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Bacterial Conjunctivitis Treatment Scope and Market Size
Bacterial Conjunctivitis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bacterial Conjunctivitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Bayer
Hoffman-LaRoche
Merck
Novartis
Pfizer
Akorn
Allergan
Perrigo
Santen Pharmaceutical
Valeant Pharmaceuticals International

Market segment by Type, the product can be split into
Fluoroquinolones
Aminoglycosides
Macrolides
Others
Market segment by Application, split into
Ointments
Eye Drops
Drugs

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bacterial Conjunctivitis Treatment Revenue
1.4 Market by Type
1.4.1 Global Bacterial Conjunctivitis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Fluoroquinolones
1.4.3 Aminoglycosides
1.4.4 Macrolides
1.4.5 Others
1.5 Market by Application
1.5.1 Global Bacterial Conjunctivitis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Ointments
1.5.3 Eye Drops
1.5.4 Drugs
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Bacterial Conjunctivitis Treatment Market Perspective (2015-2026)
2.2 Global Bacterial Conjunctivitis Treatment Growth Trends by Regions
2.2.1 Bacterial Conjunctivitis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bacterial Conjunctivitis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Bacterial Conjunctivitis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bacterial Conjunctivitis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Bacterial Conjunctivitis Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Bacterial Conjunctivitis Treatment Players by Market Size
3.1.1 Global Top Bacterial Conjunctivitis Treatment Players by Revenue (2015-2020)
3.1.2 Global Bacterial Conjunctivitis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Bacterial Conjunctivitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bacterial Conjunctivitis Treatment Market Concentration Ratio
3.2.1 Global Bacterial Conjunctivitis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bacterial Conjunctivitis Treatment Revenue in 2019
3.3 Bacterial Conjunctivitis Treatment Key Players Head office and Area Served
3.4 Key Players Bacterial Conjunctivitis Treatment Product Solution and Service
3.5 Date of Enter into Bacterial Conjunctivitis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Bacterial Conjunctivitis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Bacterial Conjunctivitis Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020)
5.2 Global Bacterial Conjunctivitis Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Bacterial Conjunctivitis Treatment Market Size (2015-2020)
6.2 Bacterial Conjunctivitis Treatment Key Players in North America (2019-2020)
6.3 North America Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020)
6.4 North America Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Bacterial Conjunctivitis Treatment Market Size (2015-2020)
7.2 Bacterial Conjunctivitis Treatment Key Players in Europe (2019-2020)
7.3 Europe Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020)
7.4 Europe Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020)

8 China
8.1 China Bacterial Conjunctivitis Treatment Market Size (2015-2020)
8.2 Bacterial Conjunctivitis Treatment Key Players in China (2019-2020)
8.3 China Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020)
8.4 China Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Bacterial Conjunctivitis Treatment Market Size (2015-2020)
9.2 Bacterial Conjunctivitis Treatment Key Players in Japan (2019-2020)
9.3 Japan Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020)
9.4 Japan Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Bacterial Conjunctivitis Treatment Market Size (2015-2020)
10.2 Bacterial Conjunctivitis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020)

11 India
11.1 India Bacterial Conjunctivitis Treatment Market Size (2015-2020)
11.2 Bacterial Conjunctivitis Treatment Key Players in India (2019-2020)
11.3 India Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020)
11.4 India Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Bacterial Conjunctivitis Treatment Market Size (2015-2020)
12.2 Bacterial Conjunctivitis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Bayer
13.1.1 Bayer Company Details
13.1.2 Bayer Business Overview
13.1.3 Bayer Bacterial Conjunctivitis Treatment Introduction
13.1.4 Bayer Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020))
13.1.5 Bayer Recent Development
13.2 Hoffman-LaRoche
13.2.1 Hoffman-LaRoche Company Details
13.2.2 Hoffman-LaRoche Business Overview
13.2.3 Hoffman-LaRoche Bacterial Conjunctivitis Treatment Introduction
13.2.4 Hoffman-LaRoche Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020)
13.2.5 Hoffman-LaRoche Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Bacterial Conjunctivitis Treatment Introduction
13.3.4 Merck Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Bacterial Conjunctivitis Treatment Introduction
13.4.4 Novartis Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Bacterial Conjunctivitis Treatment Introduction
13.5.4 Pfizer Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Akorn
13.6.1 Akorn Company Details
13.6.2 Akorn Business Overview
13.6.3 Akorn Bacterial Conjunctivitis Treatment Introduction
13.6.4 Akorn Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020)
13.6.5 Akorn Recent Development
13.7 Allergan
13.7.1 Allergan Company Details
13.7.2 Allergan Business Overview
13.7.3 Allergan Bacterial Conjunctivitis Treatment Introduction
13.7.4 Allergan Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020)
13.7.5 Allergan Recent Development
13.8 Perrigo
13.8.1 Perrigo Company Details
13.8.2 Perrigo Business Overview
13.8.3 Perrigo Bacterial Conjunctivitis Treatment Introduction
13.8.4 Perrigo Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020)
13.8.5 Perrigo Recent Development
13.9 Santen Pharmaceutical
13.9.1 Santen Pharmaceutical Company Details
13.9.2 Santen Pharmaceutical Business Overview
13.9.3 Santen Pharmaceutical Bacterial Conjunctivitis Treatment Introduction
13.9.4 Santen Pharmaceutical Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020)
13.9.5 Santen Pharmaceutical Recent Development
13.10 Valeant Pharmaceuticals International
13.10.1 Valeant Pharmaceuticals International Company Details
13.10.2 Valeant Pharmaceuticals International Business Overview
13.10.3 Valeant Pharmaceuticals International Bacterial Conjunctivitis Treatment Introduction
13.10.4 Valeant Pharmaceuticals International Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020)
13.10.5 Valeant Pharmaceuticals International Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Bacterial Conjunctivitis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Bacterial Conjunctivitis Treatment Revenue
Table 3. Ranking of Global Top Bacterial Conjunctivitis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bacterial Conjunctivitis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fluoroquinolones
Table 6. Key Players of Aminoglycosides
Table 7. Key Players of Macrolides
Table 8. Key Players of Others
Table 9. Global Bacterial Conjunctivitis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Bacterial Conjunctivitis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Bacterial Conjunctivitis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Bacterial Conjunctivitis Treatment Market Share by Regions (2015-2020)
Table 13. Global Bacterial Conjunctivitis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Bacterial Conjunctivitis Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Bacterial Conjunctivitis Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Bacterial Conjunctivitis Treatment Players
Table 20. Global Bacterial Conjunctivitis Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Bacterial Conjunctivitis Treatment Market Share by Players (2015-2020)
Table 22. Global Top Bacterial Conjunctivitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Conjunctivitis Treatment as of 2019)
Table 23. Global Bacterial Conjunctivitis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Bacterial Conjunctivitis Treatment Product Solution and Service
Table 26. Date of Enter into Bacterial Conjunctivitis Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Bacterial Conjunctivitis Treatment Market Size Share by Type (2015-2020)
Table 30. Global Bacterial Conjunctivitis Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Bacterial Conjunctivitis Treatment Market Size Share by Application (2015-2020)
Table 32. Global Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Bacterial Conjunctivitis Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Bacterial Conjunctivitis Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Bacterial Conjunctivitis Treatment Market Share (2019-2020)
Table 36. North America Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Bacterial Conjunctivitis Treatment Market Share by Type (2015-2020)
Table 38. North America Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Bacterial Conjunctivitis Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Bacterial Conjunctivitis Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Bacterial Conjunctivitis Treatment Market Share (2019-2020)
Table 42. Europe Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Bacterial Conjunctivitis Treatment Market Share by Type (2015-2020)
Table 44. Europe Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Bacterial Conjunctivitis Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Bacterial Conjunctivitis Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Bacterial Conjunctivitis Treatment Market Share (2019-2020)
Table 48. China Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Bacterial Conjunctivitis Treatment Market Share by Type (2015-2020)
Table 50. China Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Bacterial Conjunctivitis Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Bacterial Conjunctivitis Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Bacterial Conjunctivitis Treatment Market Share (2019-2020)
Table 54. Japan Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Bacterial Conjunctivitis Treatment Market Share by Type (2015-2020)
Table 56. Japan Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Bacterial Conjunctivitis Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Bacterial Conjunctivitis Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Bacterial Conjunctivitis Treatment Market Share (2019-2020)
Table 60. Southeast Asia Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Bacterial Conjunctivitis Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Bacterial Conjunctivitis Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Bacterial Conjunctivitis Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Bacterial Conjunctivitis Treatment Market Share (2019-2020)
Table 66. India Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Bacterial Conjunctivitis Treatment Market Share by Type (2015-2020)
Table 68. India Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Bacterial Conjunctivitis Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Bacterial Conjunctivitis Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Bacterial Conjunctivitis Treatment Market Share (2019-2020)
Table 72. Central & South America Bacterial Conjunctivitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Bacterial Conjunctivitis Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Bacterial Conjunctivitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Bacterial Conjunctivitis Treatment Market Share by Application (2015-2020)
Table 76. Bayer Company Details
Table 77. Bayer Business Overview
Table 78. Bayer Product
Table 79. Bayer Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020) (Million US$)
Table 80. Bayer Recent Development
Table 81. Hoffman-LaRoche Company Details
Table 82. Hoffman-LaRoche Business Overview
Table 83. Hoffman-LaRoche Product
Table 84. Hoffman-LaRoche Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020) (Million US$)
Table 85. Hoffman-LaRoche Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Product
Table 89. Merck Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020) (Million US$)
Table 90. Merck Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Product
Table 94. Novartis Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020) (Million US$)
Table 95. Novartis Recent Development
Table 96. Pfizer Company Details
Table 97. Pfizer Business Overview
Table 98. Pfizer Product
Table 99. Pfizer Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020) (Million US$)
Table 100. Pfizer Recent Development
Table 101. Akorn Company Details
Table 102. Akorn Business Overview
Table 103. Akorn Product
Table 104. Akorn Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020) (Million US$)
Table 105. Akorn Recent Development
Table 106. Allergan Company Details
Table 107. Allergan Business Overview
Table 108. Allergan Product
Table 109. Allergan Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020) (Million US$)
Table 110. Allergan Recent Development
Table 111. Perrigo Business Overview
Table 112. Perrigo Product
Table 113. Perrigo Company Details
Table 114. Perrigo Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020) (Million US$)
Table 115. Perrigo Recent Development
Table 116. Santen Pharmaceutical Company Details
Table 117. Santen Pharmaceutical Business Overview
Table 118. Santen Pharmaceutical Product
Table 119. Santen Pharmaceutical Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020) (Million US$)
Table 120. Santen Pharmaceutical Recent Development
Table 121. Valeant Pharmaceuticals International Company Details
Table 122. Valeant Pharmaceuticals International Business Overview
Table 123. Valeant Pharmaceuticals International Product
Table 124. Valeant Pharmaceuticals International Revenue in Bacterial Conjunctivitis Treatment Business (2015-2020) (Million US$)
Table 125. Valeant Pharmaceuticals International Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bacterial Conjunctivitis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Fluoroquinolones Features
Figure 3. Aminoglycosides Features
Figure 4. Macrolides Features
Figure 5. Others Features
Figure 6. Global Bacterial Conjunctivitis Treatment Market Share by Application: 2020 VS 2026
Figure 7. Ointments Case Studies
Figure 8. Eye Drops Case Studies
Figure 9. Drugs Case Studies
Figure 10. Bacterial Conjunctivitis Treatment Report Years Considered
Figure 11. Global Bacterial Conjunctivitis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Bacterial Conjunctivitis Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Bacterial Conjunctivitis Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Bacterial Conjunctivitis Treatment Market Share by Players in 2019
Figure 16. Global Top Bacterial Conjunctivitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Conjunctivitis Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Bacterial Conjunctivitis Treatment Revenue in 2019
Figure 18. North America Bacterial Conjunctivitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Bacterial Conjunctivitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Bacterial Conjunctivitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Bacterial Conjunctivitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Bacterial Conjunctivitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Bacterial Conjunctivitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Bacterial Conjunctivitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

細菌性結膜炎薬の世界市場（～2026年）

Global Bacterial Conjunctivitis Drugs Market Insights and Forecast to 2026
MRC2-11QY02898 2020年11月20日 112Pages
当調査資料は細菌性結膜炎薬のグローバル市場について調査・分析したレポートです。種類別（フルオロキノロン、アミノグリコシド、マクロライド、その他）市場規模、用途別（感染性（ウイルス性・細菌性）、アレルギー性、刺激性（化学的））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

結膜炎治療薬の世界市場（～2026年）

Global Conjunctivitis Drugs Market Size, Status and Forecast 2020-2026
MRC2-11QY11472 2020年11月25日 91Pages
当調査資料は結膜炎治療薬のグローバル市場について調査・分析したレポートです。種類別（抗生物質、肥満細胞安定剤、ステロイド、その他）市場規模、用途別（病院、自己管理）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オース...

ウイルス性結膜炎治療薬の世界市場（～2026年）

Global Viral Conjunctivitis Drugs Market Size, Status and Forecast 2020-2026
MRC2-11QY05030 2020年11月20日 90Pages
当調査資料はウイルス性結膜炎治療薬のグローバル市場について調査・分析したレポートです。種類別（FST-100、APD-209）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリ...

アレルギー性結膜炎の世界市場（～2026年）

Global Allergic Conjunctivitis Market Size, Status and Forecast 2020-2026
MRC2-11QY13650 2020年11月30日 91Pages
当調査資料はアレルギー性結膜炎のグローバル市場について調査・分析したレポートです。種類別（季節性アレルギー性結膜炎、通年性アレルギー性結膜炎、巨大乳頭状結膜炎、春季カタル結膜炎、アトピー性角結膜炎）市場規模、用途別（抗ヒスタミン薬、充血除去薬、安定化薬、オロパタジン、エピナスチン、非ステロイド性抗炎...

ウイルス性結膜炎パイプライン薬剤の世界市場（～2026年）

Global Viral Conjunctivitis Pipeline Drugs Market Insights and Forecast to 2026
MRC2-11QY13025 2020年11月30日 118Pages
当調査資料はウイルス性結膜炎パイプライン薬剤のグローバル市場について調査・分析したレポートです。種類別（急性濾胞性結膜炎パイプライン薬剤、亜急性・慢性結膜炎パイプライン薬剤）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...

細菌ワクチンの世界市場（～2026年）

Global Bacterial Vaccines Market Size, Status and Forecast 2020-2026
MRC2-11QY11013 2020年11月25日 95Pages
当調査資料は細菌ワクチンのグローバル市場について調査・分析したレポートです。種類別（莢膜多糖ワクチン、トキソイドワクチン、精製タンパク質ワクチン、生弱毒化細菌ワクチン、死菌ワクチン、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ...

細菌性肺炎治療薬の世界市場（～2026年）

Global Bacterial Pneumonia Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY11012 2020年11月25日 92Pages
当調査資料は細菌性肺炎治療薬のグローバル市場について調査・分析したレポートです。種類別（抗生物質、ワクチン）市場規模、用途別（病院薬局、小売薬局、通信販売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

アレルギー性結膜炎薬の世界市場（～2026年）

Global Allergic Conjunctivitis Drug Market Insights and Forecast to 2026
MRC2-11QY02264 2020年11月20日 112Pages
当調査資料はアレルギー性結膜炎薬のグローバル市場について調査・分析したレポートです。種類別（CPC-888、CVXL-0074、ADX-102、AGN-229666、酢酸デキサメタゾンSR、その他）市場規模、用途別（クリニック、研究センター、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロ...

細菌性膣炎薬の世界市場（～2026年）

Global Bacterial Vaginosis Drugs Market Insights and Forecast to 2026
MRC2-11QY02899 2020年11月20日 116Pages
当調査資料は細菌性膣炎薬のグローバル市場について調査・分析したレポートです。種類別（経口、局所）市場規模、用途別（骨盤内炎症性疾患、早産児、尿路感染症、性感染症（STD））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド...

細菌性セルロースの世界市場（～2026年）

Global Bacterial Cellulose Market Insights and Forecast to 2026
MRC2-11QY02897 2020年11月20日 110Pages
当調査資料は細菌性セルロースのグローバル市場について調査・分析したレポートです。種類別（植物性セルロース、バクテリア性セルロース）市場規模、用途別（複合材料、不織布吸着ウェブ、紙・板紙、食品、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

細菌性結膜炎薬の世界市場（～2026年） Conjunctivitis is an inflammation of the conjunctiva - the clear membrane that covers the outermost layer of an eye and the inner surface of eyelids. Conjunctivitis is segmented into three major categories: infective (viral and bacterial), allergic, and irritant (chemical). Bacterial conjunctivitis …
結膜炎治療薬の世界市場（～2026年） Conjunctivitis, or pink eye, is inflammation of the outermost layer of the white part of the eye and the inner surface of the eyelid due to numerous causes the most common being bacterial infection. The condition is self-limiting, but in some cases results in kerato-conjunctivitis, which results in …
ウイルス性結膜炎治療薬の世界市場（～2026年） Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely t…
アレルギー性結膜炎の世界市場（～2026年） Allergic conjunctivitis is an eye inflammation caused by an allergic reaction to substances like pollen or mold spores. There are different types of allergic conjunctivitis such as seasonal allergic conjunctivitis, perennial allergic conjunctivitis, giant papillary conjunctivitis, vernal kerato conj…
ウイルス性結膜炎パイプライン薬剤の世界市場（～2026年） Market Analysis and Insights: Global Viral Conjunctivitis Pipeline Drugs Market The global Viral Conjunctivitis Pipeline Drugs market size is projected to reach US$ 51 million by 2026, from US$ 36 million in 2020, at a CAGR of 39.5%% during 2021-2026. Global Viral Conjunctivitis Pipeline Drugs Scope…